+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zenpep"

Exocrine Pancreatic Insufficiency Global Market Report 2024 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Zenpep is a brand of endocrine and metabolic disorder drugs used to treat a variety of conditions, including pancreatic exocrine insufficiency, cystic fibrosis, and short bowel syndrome. These drugs are designed to replace or supplement the enzymes that the body is unable to produce, allowing the body to better absorb and digest food. Zenpep is a combination of three enzymes: pancrelipase, protease, and lipase. These enzymes are essential for the digestion of fats, proteins, and carbohydrates. Zenpep is a popular choice for treating endocrine and metabolic disorders, as it is effective and well-tolerated. It is available in both capsule and powder form, and can be taken with or without food. The Zenpep market is highly competitive, with many companies offering similar products. Some of the major players in the market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more